These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21055895)

  • 21. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model.
    Sharabi Y; Oron-Herman M; Kamari Y; Avni I; Peleg E; Shabtay Z; Grossman E; Shamiss A
    Am J Hypertens; 2007 Feb; 20(2):206-10. PubMed ID: 17261469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid chromatography-tandem mass spectrometry of a new PPARalpha/gamma dual agonist PAR-5359 in rat plasma.
    Kim DK; Park EJ; Jeong JH; Jeon SH; Kim EJ; Shim HJ; Lim JI; Lee HS
    Arch Pharm Res; 2009 Dec; 32(12):1743-8. PubMed ID: 20162403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
    Carmona MC; Louche K; Nibbelink M; Prunet B; Bross A; Desbazeille M; Dacquet C; Renard P; Casteilla L; Pénicaud L
    Int J Obes (Lond); 2005 Jul; 29(7):864-71. PubMed ID: 15917863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor-gamma, prevents contralateral testicular ischaemia-reperfusion injury in prepubertal rats.
    Inan M; Basaran U; Dokmeci D; Kanter M; Yalcin O; Aydogdu N; Turan N
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):457-61. PubMed ID: 17439415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
    Minoura H; Takeshita S; Yamamoto T; Mabuchi M; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Ita M; Mutoh S
    Eur J Pharmacol; 2005 Sep; 519(1-2):182-90. PubMed ID: 16039648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simplified method for determination of rosiglitazone in human plasma.
    Hruska MW; Frye RF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(2):317-20. PubMed ID: 15063342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor.
    Ihm SH; Chang K; Kim HY; Baek SH; Youn HJ; Seung KB; Kim JH
    Basic Res Cardiol; 2010 May; 105(3):399-407. PubMed ID: 19902320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of ketoconazole on the pharmacokinetics of rosiglitazone in healthy subjects.
    Park JY; Kim KA; Shin JG; Lee KY
    Br J Clin Pharmacol; 2004 Oct; 58(4):397-402. PubMed ID: 15373932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
    Wu JS; Lin TN; Wu KK
    J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosiglitazone attenuates hyperglycemia-enhanced hemorrhagic transformation after transient focal ischemia in rats.
    Zhang FH; Lin YH; Huang HG; Sun JZ; Wen SQ; Lou M
    Neuroscience; 2013 Oct; 250():651-7. PubMed ID: 23892005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simple and extractionless high-performance liquid chromatographic determination of rosiglitazone in human plasma and application to pharmacokinetics in humans.
    Kim KA; Park JY
    Biomed Chromatogr; 2004 Oct; 18(8):613-5. PubMed ID: 15386508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of quercetin on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in healthy subjects.
    Kim KA; Park PW; Kim HK; Ha JM; Park JY
    J Clin Pharmacol; 2005 Aug; 45(8):941-6. PubMed ID: 16027405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
    von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
    Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of pentoxifylline on the pharmacokinetics of rosiglitazone in Wistar rats.
    Varanasi KK; Potharaju S; Rajak S; Veeraraghavan S; Mallick P; Vakkalanka SK
    Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):537-42. PubMed ID: 18985182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective effects of prostaglandin A(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation.
    Zhang HL; Gu ZL; Savitz SI; Han F; Fukunaga K; Qin ZH
    J Neurosci Res; 2008 Apr; 86(5):1132-41. PubMed ID: 18074385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects.
    Vaidyanathan S; Maboudian M; Warren V; Yeh CM; Dieterich HA; Howard D; Dole WP
    Curr Med Res Opin; 2008 Aug; 24(8):2313-26. PubMed ID: 18786303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adiponectin concentrations increase during acute FFA elevation in humans treated with rosiglitazone.
    Krzyzanowska K; Mittermayer F; Krugluger W; Roden M; Schernthaner G; Wolzt M
    Horm Metab Res; 2007 Oct; 39(10):769-72. PubMed ID: 17952842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacokinetics of pioglitazone in Thai healthy subjects.
    Wittayalertpanya S; Chompootaweep S; Thaworn N
    J Med Assoc Thai; 2006 Dec; 89(12):2116-22. PubMed ID: 17214065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study.
    Oddo M; Schmidt JM; Carrera E; Badjatia N; Connolly ES; Presciutti M; Ostapkovich ND; Levine JM; Le Roux P; Mayer SA
    Crit Care Med; 2008 Dec; 36(12):3233-8. PubMed ID: 18936695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KR-62980: a novel peroxisome proliferator-activated receptor gamma agonist with weak adipogenic effects.
    Kim KR; Lee JH; Kim SJ; Rhee SD; Jung WH; Yang SD; Kim SS; Ahn JH; Cheon HG
    Biochem Pharmacol; 2006 Aug; 72(4):446-54. PubMed ID: 16797489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.